文献速递心脑血管急症复苏、休克与脓毒症重症综合管理与镇静镇痛

院内心搏骤停:综述

In-Hospital Cardiac Arrest: A Review.
PubMed 文献 · JAMA · 2019-01-01
一句话结论美国每年院内心搏骤停超过29万例,81%为不可电击心律,治疗核心为胸外按压、通气、必要时早期除颤及处理可逆病因,高级治疗证据有限。

该综述总结院内心搏骤停的流行病学、治疗与复苏后管理。美国每年发生超过29万例成人院内心搏骤停,平均年龄66岁,58%为男性,81%为不可电击心律(无收缩或无脉电活动)。病因以心源性(50%-60%)最常见,其次为呼吸功能不全(15%-40%)。预防需建立识别恶化患者的系统及适当干预反应(如快速反应团队)。治疗关键包括胸外按压、通气、必要时早期除颤及立即处理可逆病因(如高钾血症或低氧);支持更高级治疗的证据有限。复苏后管理聚焦病因识别与治疗、血流动力学与呼吸支持及可能的神经保护策略(如目标温度管理);预后判断需综合神经恢复潜力与持续多器官衰竭,避免在缺乏明确预后征象时撤除治疗。

要点

  • 美国每年院内心搏骤停超过29万例成人,平均年龄66岁,58%为男性,81%为不可电击心律(无收缩或无脉电活动)。
  • 病因以心源性(50%-60%)最常见,其次为呼吸功能不全(15%-40%),治疗需立即处理可逆病因如高钾血症或低氧。
  • 治疗关键要素包括胸外按压、通气、必要时早期除颤及立即处理可逆病因;支持更高级治疗的证据有限。
  • 预防院内心搏骤停需建立识别恶化患者的系统及适当干预反应(如快速反应团队)。
  • 复苏后管理聚焦病因识别与治疗、血流动力学与呼吸支持及可能的神经保护策略(如目标温度管理);避免在缺乏明确预后征象时撤除治疗。

适用人群与场景

  • 美国每年超过29万例成人院内心搏骤停患者,平均年龄66岁,58%为男性。

处置流程与药物剂量

  • 治疗关键要素包括胸外按压、通气、必要时早期除颤及立即处理可逆病因(如高钾血症或低氧)。

研究设计与关键结果

  • 综述总结:美国每年发生超过29万例成人院内心搏骤停,81%为不可电击心律(无收缩或无脉电活动),病因以心源性(50%-60%)最常见,其次为呼吸功能不全(15%-40%)。

证据类型、等级与局限

  • 证据类型:综述;支持更高级治疗的证据有限。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 预防院内心搏骤停需建立识别恶化患者的系统及适当干预反应(如快速反应团队)。
  • 复苏后管理聚焦病因识别与治疗、血流动力学与呼吸支持及可能的神经保护策略(如目标温度管理);预后判断需综合神经恢复潜力与持续多器官衰竭,避免在缺乏明确预后征象时撤除治疗。
  • 鼓励医院参与国家质量改进项目。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: In-hospital cardiac arrest is common and associated with a high mortality rate. Despite this, in-hospital cardiac arrest has received little attention compared with other high-risk cardiovascular conditions, such as stroke, myocardial infarction, and out-of-hospital cardiac arrest.

OBSERVATIONS: In-hospital cardiac arrest occurs in over 290 000 adults each year in the United States. Cohort data from the United States indicate that the mean age of patients with in-hospital cardiac arrest is 66 years, 58% are men, and the presenting rhythm is most often (81%) nonshockable (ie, asystole or pulseless electrical activity). The cause of the cardiac arrest is most often cardiac (50%-60%), followed by respiratory insufficiency (15%-40%). Efforts to prevent in-hospital cardiac arrest require both a system for identifying deteriorating patients and an appropriate interventional response (eg, rapid response teams). The key elements of treatment during cardiac arrest include chest compressions, ventilation, early defibrillation, when applicable, and immediate attention to potentially reversible causes, such as hyperkalemia or hypoxia. There is limited evidence to support more advanced treatments. Post-cardiac arrest care is focused on identification and treatment of the underlying cause, hemodynamic and respiratory support, and potentially employing neuroprotective strategies (eg, targeted temperature management). Although multiple individual factors are associated with outcomes (eg, age, initial rhythm, duration of the cardiac arrest), a multifaceted approach considering both potential for neurological recovery and ongoing multiorgan failure is warranted for prognostication and clinical decision-making in the post-cardiac arrest period. Withdrawal of care in the absence of definite prognostic signs both during and after cardiac arrest should be avoided. Hospitals are encouraged to participate in national quality-improvement initiatives.

CONCLUSIONS AND RELEVANCE: An estimated 290 000 in-hospital cardiac arrests occur each year in the United States. However, there is limited evidence to support clinical decision making. An increased awareness with regard to optimizing clinical care and new research might improve outcomes.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Andersen LW, Holmberg MJ, Berg KM, et al. In-Hospital Cardiac Arrest: A Review. JAMA. 2019. PMID: 30912843. doi:10.1001/jama.2019.1696

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。